H.B. 106 Rare Disease Advisory Council
Bill status
signed
all 5 stages cleared
Introduction
Jan 2020
Committee Review
Mar 2020
House Passage
Mar 2020
Senate Passage
Mar 2020
Signed into Law
Mar 2020
Introduced Jan 27, 2020
Signed Mar 28, 2020
Floor votes · Senate Mar 11, 2020 · House Mar 6, 2020
How they voted
25–0
Passed · 4 other
Total votes 29
Mar 11, 2020
D
Democratic6
100% Yea
N
Forward1
100% Yea
R
Republican22
81% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
38
Key actions
3
Committee
6
Mar 28, 2020
Signed into law
Governor Signed
Mar 11, 2020
Senate · Passed
passed 2nd & 3rd readings/suspension
Mar 9, 2020
Senate · Reported by committee
committee report favorable
Mar 9, 2020
House · Reported by committee
Senate Comm - Favorable Recommendation
Mar 6, 2020
Senate · Referred to committee
to Senate Economic Development and Workforce Services Committee
Mar 6, 2020
Senate · Introduced
1st reading (Introduced)
Mar 6, 2020
House · Passed
passed 3rd reading
Feb 4, 2020
House · Reported by committee
committee report favorable
Feb 3, 2020
House · Reported by committee
House Comm - Favorable Recommendation
Jan 29, 2020
House · Referred to committee
to House Health and Human Services Committee
Jan 27, 2020
House · Introduced
1st reading (Introduced)
1 primary · 1 co-sponsor
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about H.B. 106
Scope: UT
Hi! I can help you understand H.B. 106. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline